Next-generation Sequencing Industry Business & Investment Opportunity (2018 – 2022) Market Research Reports

Report Scope:
The scope of the report includes clinical NGS technologies, applications, industries, initiatives, patents and companies. The markets for NGS-based diagnostics are given for the years 2015, 2016, 2017 and 2022.
 
This report reviews the main sequencing technologies and explains why genetic variation is important in clinical testing. It then discusses some of the significant research initiatives that impact clinical NGS applications. The main market driving forces are also discussed.
 
The report examines the markets by test complexity, clinical indication and test purpose. Test complexity refers to the plex level (i.e., the number of genetic markers that can be analyzed within a sample) and coverage (e.g., the extent to which the genome is covered) of the test. Examining the market by test complexity provides valuable insight into which products (e.g., sample preparation, NGS instrument, informatics, etc.) will be in demand in the future.
 
GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/2820083-next-generation-sequencing-emerging-clinical-applications-and-global-markets     
 
The report provides market data and forecasts for NGS diagnostics by specific applications, including those for cancer, cardiovascular diseases, clinical microbiology and infectious diseases, Mendelian disorders, metabolic and immune disorders, neurological disorders, reproductive health, and transplant medicine.
 
Specific geographic markets are discussed, including North America, Europe, Asia-Pacific, and the rest of the world.
 
Industry sectors analyzed include sequencing instruments, target enrichment, informatics, clinical laboratory testing services, reproductive health diagnostics, liquid biopsy, immune sequencing, HLA typing, third generation sequencing, and direct to consumer.
More than 200 companies in the clinical NGS industry are profiled in this report.
BCC Research provides a summary of the main industry acquisitions and strategic alliances from 2015 through April 2017, including key alliance trends.
 
Report Includes:
- An overview of the global market for next-generation sequencing and its emerging clinical applications.
- Analyses of global market trends, with data from 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022.
- Examination of the sequencing industry structure for key market segments.
- Discussion covering the strategies employed by the main companies in the market.
- Comprehensive company profiles of major players in the field.
 
Key Players
10X GENOMICS, INC.
23ANDME INC.
3BILLION INC.
ADAPTIVE BIOTECHNOLOGIES INC.
ADMERA HEALTH
AGILENT TECHNOLOGIES INC.
ALCEDIAG
ALMAC GROUP LTD.
AMARANTUS BIOSCIENCE HOLDINGS INC.
AMBRY GENETICS
APERIOMICS INC.
APPISTRY INC.
ARUP LABORATORIES
ASURAGEN INC.
ATHENA DIAGNOSTICS INC.
ATRECA INC.
BASE4 INNOVATION LTD.
BAYLOR MIRACA GENETICS LABORATORIES INC.
BECTON, DICKINSON AND CO.
 
Table of Content: Key Points
Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Overview
Introduction
Clinical NGS Markets
Clinical NGS Growth Driving Forces
Technology Drivers
Market Drivers
Clinical NGS Applications
…Continued        
                                  
ACCESS REPORT @ https://www.wiseguyreports.com/reports/2820083-next-generation-sequencing-emerging-clinical-applications-and-global-markets            
                                 
Contact Info:                                                         
NORAH TRENT                                                      
sales@wiseguyreports.com             
Ph: +1-646-845-9349 (US)                          
Ph: +44 208 133 9349 (UK)                                                   
                                                                             
Get in touch:                                                         
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports                                                                  
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts